Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Canntab Therapeutics Ltd (CTABF)

Canntab Therapeutics Ltd (CTABF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order Newsfile - Mon Sep 18, 2023

Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the "Corporation") announces that the Ontario Securities Commission (the...

CTABF : 0.0073 (+356.25%)
PILL.CN : 0.0050 (unch)
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET Newswire.ca - Mon Aug 22, 2022

/CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends...

PILL.CN : 0.0050 (unch)
CTABF : 0.0073 (+356.25%)
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET PR Newswire - Mon Aug 22, 2022

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene...

PILL.CN : 0.0050 (unch)
CTABF : 0.0073 (+356.25%)
CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO Newswire.ca - Tue Aug 2, 2022

/CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN)(OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene...

CTABF : 0.0073 (+356.25%)
CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO PR Newswire - Tue Aug 2, 2022

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN)(OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and...

CTABF : 0.0073 (+356.25%)
Canntab Corporate Update PR Newswire - Thu Jun 30, 2022

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene...

PILL.CN : 0.0050 (unch)
CTABF : 0.0073 (+356.25%)
Canntab Corporate Update Newswire.ca - Thu Jun 30, 2022

/CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends...

PILL.CN : 0.0050 (unch)
CTABF : 0.0073 (+356.25%)
Canntab Engages Hamish Sutherland as Strategic Advisor Newswire.ca - Wed Apr 13, 2022

/CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends...

PILL.CN : 0.0050 (unch)
CTABF : 0.0073 (+356.25%)
Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids Globe Newswire - Mon Jan 10, 2022

The agreement is anticipated to contribute to correcting the opioid crisis in Canada and serve as a foundation for both companies to potentially expand...

OTC.VN : 0.300 (unch)
LVT.CN : 0.005 (unch)
LVTTF : 0.0027 (+35.00%)
CTABF : 0.0073 (+356.25%)
Canntab Reaches Agreement with Innovative Bioinformatics Company, 36eight Technologies Inc. PR Newswire - Mon Oct 18, 2021

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and...

CTABF : 0.0073 (+356.25%)

Barchart Exclusives

Is It Too Soon to Buy Beaten-Down Peloton Stock? Barchart - 5 minutes ago
PTON is in focus amid a fresh round of buyout chatter, but is it worth buying this former pandemic-era standout for the potential Hail Mary upside? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot